Skip to search formSkip to main contentSkip to account menu

PG-501

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

mazaticol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1974
1974
A comparison of the inhibitory effects of certain antiparkinsonian agents on dopamine accumulation into the rat striatum.
The inhibitory effect of certain centrally acting drugs, including antiparkinsonian agents, tricyclic antidepressant and… 
1972
1972
Metabolic fate of 6,6,9-trimethyl-9-azabicyclo(3,3,1)non-3 -yl , -di(2-thienyl)glycolate hydrochloride monohydrate (PG-501).
1972
1972
[Absorption, distribution and excretion of 14 C-labelled 6,6,9-trimethyl-9-azabicyclo(3,3,1)non-3 -yl a,a-di(2-thienyl)glycolate hydrochloride monohydrate (PG-501)].
1971
1971
The Beneficial Effect of PG-501 on Parkinsonism
We undertooka clinical evaluation of PG-501, 6, 6, 9-trimethyl-9-azabicyclo [3, 3, 1] non-3 β-yl α, α-di (2-thienyl) glycolate… 
1971
1971
[Pharmacological properties of 6,6,9-trimethyl-9-azabicyclo (3,3,1)non-3 beta-yl-alpha, alpha-di(2-thienyl) glycolate hydrochloride monohydrate (PG-501), a new anti-parkinsonian agent].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)